Mathieu Giraud

Mathieu Giraud

Auto-generated profile, based on publicly available information

Mathieu Giraud

University of Lille

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2019 in Leukemia
Verified
Journal Article
Open access
PDF file
OGon behalf of the EuroClonality-NGS working group
on behalf of the EuroClonality-NGS working group
MBMonika Brüggemann
Monika Brüggemann
MKMichaela Kotrová
Michaela Kotrová
HKHenrik Knecht
Henrik Knecht
JBJack Bartram
Jack Bartram
ALAnton W. Langerak
Anton W. Langerak
Amplicon-based next-generation sequencing (NGS) of immunoglobulin (IG) and T-cell receptor (TR) gene rearrangements for clonality assessment, marker identification and quantification of minimal residual disease (MRD) in lymphoid neoplasms has been the focus of intense research, development and application. However, standardization and validation in a scientifically controlled multicentre setting is still lacking. Therefore, IG/TR assay development and design, including bioinformatics, was performed within the EuroClonality-NGS working group and validated for MRD marker identification in acute lymphoblastic leukaemia (ALL). Five EuroMRD ALL reference laboratories performed IG/TR NGS in 50 diagnostic ALL samples, and compared results with those generated through routine IG/TR Sanger sequencing. A central polytarget quality control (cPT-QC) was used to monitor primer performance, and a central in-tube quality control (cIT-QC) was spiked into each sample as a library-specific quality control and calibrator. NGS identified 259 (average 5.2/sample, range 0–14) clonal sequences vs. Sanger-sequencing 248 (average 5.0/sample, range 0–14). NGS primers covered possible IG/TR rearrangement types more completely compared with local multiplex PCR sets and enabled sequencing of bi-allelic rearrangements and weak PCR products. The cPT-QC showed high reproducibility across all laboratories. These validated and reproducible quality-controlled EuroClonality-NGS assays can be used for standardized NGS-based identification of IG/TR markers in lymphoid malignancies.

28 September 2005 in Genome Biology
Verified
Journal Article
Open access
PDF file
PQPascale Quignon
Pascale Quignon
MGMathieu Giraud
Mathieu Giraud
MRMaud Rimbault
Maud Rimbault
PLPatricia Lavigne
Patricia Lavigne
STSandrine Tacher
Sandrine Tacher
FGFrancis Galibert
Francis Galibert
Background: Dogs and rats have a highly developed capability to detect and identify odorant molecules, even at minute concentrations. Previous analyses have shown that the olfactory receptors (ORs) that specifically bind odorant molecules are encoded by the largest gene family sequenced in mammals so far. Results: We identified five amino acid patterns characteristic of ORs in the recently sequenced boxer dog and brown Norway rat genomes. Using these patterns, we retrieved 1,094 dog genes and 1,493 rat genes from these shotgun sequences. The retrieved sequences constitute the olfactory receptor repertoires of these two animals. Subsets of 20.3% (for the dog) and 19.5% (for the rat) of these genes were annotated as pseudogenes as they had one or several mutations interrupting their open reading frames. We performed phylogenetic studies and organized these two repertoires into classes, families and subfamilies. Conclusion: We have established a complete or almost complete list of OR genes in the dog and the rat and have compared the sequences of these genes within and between the two species. Our results provide insight into the evolutionary development of these genes and the local amplifications that have led to the specific amplification of many subfamilies. We have also compared the human and rat ORs with the human and mouse OR repertoires.

11 November 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MDMarc Duez
Marc Duez
MGMathieu Giraud
Mathieu Giraud
RHRyan Herbert
Ryan Herbert
TRTatiana Rocher
Tatiana Rocher
MSMikaël Salson
Mikaël Salson
FTFlorian Thonier
Florian Thonier
The B and T lymphocytes are white blood cells playing a key role in the adaptive immunity. A part of their DNA, called the V(D)J recombinations, is specific to each lymphocyte, and enables recognition of specific antigenes. Today, with new sequencing techniques, one can get billions of DNA sequences from these regions. With dedicated Repertoire Sequencing (RepSeq) methods, it is now possible to picture population of lymphocytes, and to monitor more accurately the immune response as well as pathologies such as leukemia. Vidjil is an open-source platform for the interactive analysis of high-throughput sequencing data from lymphocyte recombinations. It contains an algorithm gathering reads into clonotypes according to their V(D)J junctions, a web application made of a sample, experiment and patient database and a visualization for the analysis of clonotypes along the time. Vidjil is implemented in C++, Python and Javascript and licensed under the GPLv3 open-source license. Source code, binaries and a public web server are available at http://www.vidjil.org and at http://bioinfo.lille.inria.fr/vidjil. Using the Vidjil web application consists of four steps: 1. uploading a raw sequence file (typically a FASTQ); 2. running RepSeq analysis software; 3. visualizing the results; 4. annotating the results and saving them for future use. For the end-user, the Vidjil web application needs no specific installation and just requires a connection and a modern web browser. Vidjil is used by labs in hematology or immunology for research and clinical applications.

20 August 2015 in Blood
Verified
Journal Article
Open access
PDF file
MKMichaela Kotrová
Michaela Kotrová
KMKaterina Muzikova
Katerina Muzikova
EMEster Mejstrikova
Ester Mejstrikova
MNMichaela Novakova
Michaela Novakova
VBVioleta Bakardjieva-Mihaylova
Violeta Bakardjieva-Mihaylova
EFEva Fronkova
Eva Fronkova

28 May 2014 in BMC Genomics
Verified
Journal Article
Open access
PDF file
MGMathieu Giraud
Mathieu Giraud
MSMikaël Salson
Mikaël Salson
MDMarc Duez
Marc Duez
CVCéline Villenet
Céline Villenet
SQSabine Quief
Sabine Quief
MFMartin Figeac
Martin Figeac
V(D)J recombinations in lymphocytes are essential for immunological diversity. They are also useful markers of pathologies. In leukemia, they are used to quantify the minimal residual disease during patient follow-up. However, the full breadth of lymphocyte diversity is not fully understood. We propose new algorithms that process high-throughput sequencing (HTS) data to extract unnamed V(D)J junctions and gather them into clones for quantification. This analysis is based on a seed heuristic and is fast and scalable because in the first phase, no alignment is performed with germline database sequences. The algorithms were applied to TR γ HTS data from a patient with acute lymphoblastic leukemia, and also on data simulating hypermutations. Our methods identified the main clone, as well as additional clones that were not identified with standard protocols. The proposed algorithms provide new insight into the analysis of high-throughput sequencing data for leukemia, and also to the quantitative assessment of any immunological profile. The methods described here are implemented in a C++ open-source program called Vidjil.

15 May 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
TCthe EuroClonality-NGS Consortium
the EuroClonality-NGS Consortium
ALAnton W. Langerak
Anton W. Langerak
MBMonika Brüggemann
Monika Brüggemann
FDFrédéric Davi
Frédéric Davi
NDNikos Darzentas
Nikos Darzentas
KSKostas Stamatopoulos
Kostas Stamatopoulos
Analysis and interpretation of Ig and TCR gene rearrangements in the conventional, low-throughput way have their limitations in terms of resolution, coverage, and biases. With the advent of high-throughput, next-generation sequencing (NGS) technologies, a deeper analysis of Ig and/or TCR (IG/TR) gene rearrangements is now within reach, which impacts on all main applications of IG/TR immunogenetic analysis. To bridge the generation gap from low- to high-throughput analysis, the EuroClonality-NGS Consortium has been formed, with the main objectives to develop, standardize, and validate the entire workflow of IG/TR NGS assays for 1) clonality assessment, 2) minimal residual disease detection, and 3) repertoire analysis. This concerns the preanalytical (sample preparation, target choice), analytical (amplification, NGS), and postanalytical (immunoinformatics) phases. Here we critically discuss pitfalls and challenges of IG/TR NGS methodology and its applications in hemato-oncology and immunology.